Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Comvita Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Comvita şirketinin toplam hissedar öz sermayesi NZ$160.6M ve toplam borcu NZ$87.9M olup, bu da borç-öz sermaye oranını 54.7% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla NZ$307.9M ve NZ$147.2M dir.

Anahtar bilgiler

54.7%

Borç/özkaynak oranı

NZ$87.86m

Borç

Faiz karşılama oranı	n/a
Nakit	NZ$8.16m
Eşitlik	NZ$160.63m
Toplam yükümlülükler	NZ$147.23m
Toplam varlıklar	NZ$307.86m

Son finansal sağlık güncellemeleri

Here's Why Comvita (NZSE:CVT) Is Weighed Down By Its Debt Load

Mar 21

These 4 Measures Indicate That Comvita (NZSE:CVT) Is Using Debt Reasonably Well

Mar 25

Recent updates

Here's Why Comvita (NZSE:CVT) Is Weighed Down By Its Debt Load

Mar 21

Comvita Limited's (NZSE:CVT) 26% Dip In Price Shows Sentiment Is Matching Earnings

Feb 05

How Much Did Comvita's(NZSE:CVT) Shareholders Earn From Share Price Movements Over The Last Three Years?

Dec 22

Could The Comvita Limited (NZSE:CVT) Ownership Structure Tell Us Something Useful?

Nov 25

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: CVT 'nin kısa vadeli varlıkları ( NZ$192.9M ) kısa vadeli yükümlülüklerini ( NZ$130.5M ) aşıyor.

Uzun Vadeli Yükümlülükler: CVT şirketinin kısa vadeli varlıkları ( NZ$192.9M ) uzun vadeli yükümlülüklerini ( NZ$16.7M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: CVT 'nin net borç/öz sermaye oranı ( 49.6% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: CVT 'nin borç/öz sermaye oranı son 5 yılda 57.3% seviyesinden 54.7% seviyesine düştü.

Borç Kapsamı: CVT 'nin borcu işletme nakit akışı ( 6.1% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: CVT şirketinin borçlarına ilişkin faiz ödemelerinin EBIT tarafından iyi bir şekilde karşılanıp karşılanmadığını belirlemek için yeterli veri yok.

Comvita Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Here's Why Comvita (NZSE:CVT) Is Weighed Down By Its Debt Load

These 4 Measures Indicate That Comvita (NZSE:CVT) Is Using Debt Reasonably Well

Recent updates

Comvita Limited, Annual General Meeting, Oct 30, 2024

New major risk - Financial position

Consensus EPS estimates have been downgraded.

Full year 2024 earnings released: NZ$1.10 loss per share (vs NZ$0.16 profit in FY 2023)

Now 30% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 18%

Upcoming dividend of NZ$0.012 per share

Here's Why Comvita (NZSE:CVT) Is Weighed Down By Its Debt Load

First half 2024 earnings released: NZ$0.046 loss per share (vs NZ$0.06 profit in 1H 2023)

Investor sentiment improves as stock rises 21%

Now 28% overvalued

Comvita Limited's (NZSE:CVT) 26% Dip In Price Shows Sentiment Is Matching Earnings

Consensus EPS estimates fall by 46%

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

Consensus EPS estimates fall by 56%

Price target decreased by 24% to NZ$3.35

A Look At The Fair Value Of Comvita Limited (NZSE:CVT)

Comvita Limited (NZSE:CVT) acquired an additional 12% stake in Apiter Laboratories for $2 million.

Less than half of directors are independent

Comvita Limited Approves the Appointment of Michael Sang as Director

Upcoming dividend of NZ$0.035 per share at 1.7% yield

Key Executive recently sold NZ$379k worth of stock

Consensus EPS estimates fall by 18%

New minor risk - Earnings quality

Comvita Limited Announces Final Fully Imputed Dividend for the Full Year 2023

Full year 2023 earnings: EPS misses analyst expectations

Comvita Limited, Annual General Meeting, Oct 04, 2023

Investor sentiment improves as stock rises 16%

CEO, MD & Director recently sold NZ$86k worth of stock

Upcoming dividend of NZ$0.029 per share at 1.9% yield

Independent Director recently sold NZ$101k worth of stock

Consensus EPS estimates fall by 15%

First half 2023 earnings released: EPS: NZ$0.06 (vs NZ$0.05 in 1H 2022)

Price target increased to NZ$4.50

High number of new directors

Upcoming dividend of NZ$0.035 per share

High number of new directors

Price target increased to NZ$4.50

Comvita Limited Provides Earnings Guidance for the Year 2023

Comvita Limited, Annual General Meeting, Sep 29, 2022

Insider recently bought NZ$63k worth of stock

Upcoming dividend of NZ$0.029 per share

First half 2022 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of NZ$0.047 per share

Price target increased to NZ$3.70

Full year 2021 earnings released: EPS NZ$0.14 (vs NZ$0.19 loss in FY 2020)

Consensus forecasts updated

These 4 Measures Indicate That Comvita (NZSE:CVT) Is Using Debt Reasonably Well

Comvita Launches Special Reserve Manuka and OneHive Movement

We Think Comvita's (NZSE:CVT) Robust Earnings Are Conservative

Is It Too Late To Consider Buying Comvita Limited (NZSE:CVT)?

First half 2021 earnings released: EPS NZ$0.05 (vs NZ$0.26 loss in 1H 2020)

Have Insiders Been Buying Comvita Limited (NZSE:CVT) Shares This Year?

How Much Did Comvita's(NZSE:CVT) Shareholders Earn From Share Price Movements Over The Last Three Years?

New 90-day high: NZ$3.40

Could The Comvita Limited (NZSE:CVT) Ownership Structure Tell Us Something Useful?

Full year earnings released - NZ$0.19 loss per share

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin